Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Colman

Showing results (161-170 of 646) with videos related to

Pageof 65
Sort By:
Methods in Enzymology|January 1, 1988
C1 inhibitor: the predominant inhibitor of plasma kallikreinM Schapira, A de Agostini, R W Colman
Transactions of the Association of American Physicians|January 1, 1981
High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitorsM Schapira, C F Scott, R W Colman
The Journal of Laboratory and Clinical Medicine|November 1, 1992
The contribution of factor V to the coagulant property of pleural fluidE G Wyshock, S Idell, R W Colman
The Journal of Clinical Investigation|February 1, 1982
Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasmaM Schapira, C F Scott, R W Colman
The Journal of Clinical Investigation|June 1, 1974
Human platelet collagenaseC M Chesney, E Harper, R W Colman
Immunological Communications|January 1, 1973
Simple assay for prekallikrein activatorsA Bagdasarian, R C Talamo, R W Colman
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|February 1, 1989
Affective responses to activities: a comparative studyJ Boyer, W Colman, L Levy, et al.
Thrombosis Research|June 1, 2000
Inactivation of platelet PDE2 by an affinity label: 8-[(4-bromo-2, 3-dioxobutyl)thio]cAMPF Mseeh, R F Colman, R W Colman
The Journal of Clinical Investigation|August 1, 1983
Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variantsH C Chiu, E Whitaker, R W Colman
The Journal of Thoracic and Cardiovascular Surgery|June 11, 1991
Invited letter concerning: aprotininL H Edmunds, S Niewiarowski, R W Colman
Pageof 65

Showing results (161-170 of 646) with videos related to

Sort By:
Pageof 65
Methods in Enzymology|January 1, 1988
C1 inhibitor: the predominant inhibitor of plasma kallikreinM Schapira, A de Agostini, R W Colman
Transactions of the Association of American Physicians|January 1, 1981
High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitorsM Schapira, C F Scott, R W Colman
The Journal of Laboratory and Clinical Medicine|November 1, 1992
The contribution of factor V to the coagulant property of pleural fluidE G Wyshock, S Idell, R W Colman
The Journal of Clinical Investigation|February 1, 1982
Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasmaM Schapira, C F Scott, R W Colman
The Journal of Clinical Investigation|June 1, 1974
Human platelet collagenaseC M Chesney, E Harper, R W Colman
Immunological Communications|January 1, 1973
Simple assay for prekallikrein activatorsA Bagdasarian, R C Talamo, R W Colman
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|February 1, 1989
Affective responses to activities: a comparative studyJ Boyer, W Colman, L Levy, et al.
Thrombosis Research|June 1, 2000
Inactivation of platelet PDE2 by an affinity label: 8-[(4-bromo-2, 3-dioxobutyl)thio]cAMPF Mseeh, R F Colman, R W Colman
The Journal of Clinical Investigation|August 1, 1983
Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variantsH C Chiu, E Whitaker, R W Colman
The Journal of Thoracic and Cardiovascular Surgery|June 11, 1991
Invited letter concerning: aprotininL H Edmunds, S Niewiarowski, R W Colman
Pageof 65